Jun 2026 (Q2 FY26) — Jul 29, 2026
Option Care Health Q2 FY26 — Strong Q2 Performance and Strategic Momentum
Read the full callOption Care Health (OPCH) earnings
- Mar 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Option Care Health earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,351 | +1.3% YoY | Quarterly, as filed | Quarter to Mar 2026 | Revenue from operations as filed. |
| Operating margin | 5.4 | −0.6 pts YoY | Operating profit / revenue | Quarter to Mar 2026 | For the quarter; a change is in percentage points. |
| Net profit | 45.3 | −3.0% YoY | Quarterly, as filed | Quarter to Mar 2026 | Profit after tax as filed. |
Price
$31.21 +0.03% · +$0.01
Performance +12.4% 1Y
1Y: $27.77 on 17 Oct 2025 → $31.21. High $36.59 (22 Jan 2026), low $19.52 (15 May 2026).
- Previous close
- $31.2
- 52-week range
- $19.52 – $36.59
- One year
- +9.97%
Overview
- Symbol
- OPCH
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Option Care Health earnings calls (OPCH)
Financials
What the filings say
Net profit, year on year: −3% (quarter to mar 2026 against mar 2025).
| Line item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,227 | 1,279 | 1,346 | 1,333 | 1,416 | 1,435 | 1,465 | 1,351 |
| Operating profit | 81 | 85 | 87 | 79 | 83 | 85 | 92 | 73 |
| Operating margin | 6.6% | 6.7% | 6.5% | 5.9% | 5.8% | 5.9% | 6.2% | 5.4% |
| Other income | — | — | — | -16 | — | — | — | -12 |
| Interest | 13 | 12 | 11 | 13 | 14 | 14 | 13 | 13 |
| Profit before tax | 72 | 74 | 81 | 64 | 69 | 69 | 82 | 61 |
| Tax rate | 26.4% | 26.8% | 25.8% | 26.5% | 26.6% | 24.9% | 28.2% | 25.7% |
| Net profit | 53 | 54 | 60 | 47 | 51 | 52 | 59 | 45 |
| EPS ($ per share) | 0.31 | 0.32 | — | 0.28 | 0.31 | 0.32 | — | 0.29 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -16 | -92 | -100 | 40 | 190 | 458 | 669 | 877 |
| Total liabilities | 825 | 1,683 | 1,632 | 1,615 | 1,727 | 1,795 | 2,018 | 2,129 |
| Fixed assets | 93 | 133 | 121 | 112 | 108 | 121 | 127 | 139 |
| Total assets | 1,428 | 2,590 | 2,647 | 2,791 | 3,113 | 3,217 | 3,422 | 3,456 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 24 | 39 | 127 | 209 | 268 | 371 | 323 | 258 |
| Cash from investing | -37 | -728 | -26 | -112 | -108 | -57 | -36 | -161 |
| Cash from financing | -4 | 719 | -69 | -77 | 15 | -265 | -218 | -277 |
| Net cash flow | -17 | 31 | 32 | 20 | 175 | 50 | 69 | -180 |
| Capital expenditure | -26 | -28 | -27 | -26 | -35 | -42 | -36 | -41 |
| Free cash flow | -2 | 11 | 101 | 183 | 232 | 329 | 288 | 217 |
Insider filings
57 filings between Nov 3, 2025 and Jul 6, 2026.
Open market
decisions to buy or sellPurchases
$2.86M
5 purchases by 4 insiders
Sales
$1.17M
2 sales by 2 insiders
Compensation
not trading decisions- 22
- Award — granted as compensation
- 2
- Option exercise — converted options into shares
- 26
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| KRAEMER HARRY M JANSEN JR | $1.77M | — | May 4, 2026 |
| Pate R Carter | — | $970.6K | Feb 27, 2026 |
| SULLIVAN TIMOTHY P | $499.7K | — | May 7, 2026 |
| Sethna Meenal | $327.1K | — | May 4, 2026 |
| RADEMACHER JOHN CHARLES | $264.7K | — | May 4, 2026 |
| Bavaro Michael | — | $198.0K | Feb 27, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 6, 2026 | Bhatia Prateek EVP Sp Sales & Solutions | Award | 23,409 | $0 |
| Jul 6, 2026 | Bhatia Prateek EVP Sp Sales & Solutions | Award | 16,386 | $0 |
| May 20, 2026 | KRAEMER HARRY M JANSEN JR Director | Award | 12,079 | $268.5K |
| May 20, 2026 | BRANDT ERIC Director | Award | 2,643 | $58.8K |
| May 20, 2026 | KRAEMER HARRY M JANSEN JR Director | Award | 8,997 | $0 |
| May 20, 2026 | Deckmann Natasha Director | Award | 844 | $18.8K |
| May 20, 2026 | Deckmann Natasha Director | Award | 8,997 | $0 |
| May 20, 2026 | Wright Norman L. Director | Award | 8,997 | $0 |
| May 20, 2026 | BRANDT ERIC Director | Award | 8,997 | $0 |
| May 20, 2026 | SULLIVAN TIMOTHY P Director | Award | 4,836 | $107.5K |
| May 20, 2026 | Pate R Carter Director | Award | 8,997 | $0 |
| May 20, 2026 | Bodem Barbara W. Director | Award | 8,997 | $0 |
| May 20, 2026 | Bierbower Elizabeth D Director | Award | 8,997 | $0 |
| May 20, 2026 | SULLIVAN TIMOTHY P Director | Award | 8,997 | $0 |
| May 19, 2026 | Smyser Collin GC & Corporate Secretary | Option exercise | 812 | $0 |
| May 19, 2026 | Smyser Collin GC & Corporate Secretary | Tax withheld | 360 | $7.5K |
| May 7, 2026 | SULLIVAN TIMOTHY P Director | Purchase | 24,154 | $499.7K |
| May 4, 2026 | KRAEMER HARRY M JANSEN JR Director | Purchase | 36,610 | $783.8K |
| May 4, 2026 | RADEMACHER JOHN CHARLES Chief Executive Officer | Purchase | 12,500 | $264.7K |
| May 4, 2026 | Sethna Meenal Chief Financial Officer | Purchase | 16,225 | $327.1K |
| Apr 22, 2026 | Adewunmi Femi Chief Medical Officer | Tax withheld | 1,396 | $39.6K |
| Feb 27, 2026 | Bavaro Michael Chief Human Resources Officer | Sale | 6,000 | $198.0K |
| Feb 27, 2026 | Pate R Carter Director | Sale | 30,287 | $970.6K |
| Feb 24, 2026 | Smyser Collin GC & Corporate Secretary | Tax withheld | 2,210 | $74.7K |
| Feb 24, 2026 | Grashoff Christopher L. Chief Growth Officer | Tax withheld | 1,980 | $67.0K |
| Feb 24, 2026 | Bavaro Michael Chief Human Resources Officer | Tax withheld | 1,354 | $45.8K |
| Feb 24, 2026 | Adewunmi Femi Chief Medical Officer | Tax withheld | 1,627 | $55.0K |
| Feb 24, 2026 | Maggio Nicole Chief Accounting Officer | Tax withheld | 975 | $33.0K |
| Feb 24, 2026 | RADEMACHER JOHN CHARLES Chief Executive Officer | Tax withheld | 11,050 | $373.7K |
| Feb 24, 2026 | Whitworth Luke Chief Operating Officer | Tax withheld | 4,605 | $155.7K |
| Feb 22, 2026 | Bavaro Michael Chief Human Resources Officer | Tax withheld | 12,212 | $435.8K |
| Feb 22, 2026 | Grashoff Christopher L. Chief Growth Officer | Tax withheld | 538 | $19.2K |
| Feb 22, 2026 | Maggio Nicole Chief Accounting Officer | Tax withheld | 372 | $13.3K |
| Feb 22, 2026 | Whitworth Luke Chief Operating Officer | Tax withheld | 24,029 | $857.6K |
| Feb 22, 2026 | RADEMACHER JOHN CHARLES Chief Executive Officer | Tax withheld | 132,848 | $4.74M |
| Feb 22, 2026 | Smyser Collin GC & Corporate Secretary | Tax withheld | 15,433 | $550.8K |
| Feb 21, 2026 | RADEMACHER JOHN CHARLES Chief Executive Officer | Option exercise | 11,087 | $0 |
| Feb 21, 2026 | RADEMACHER JOHN CHARLES Chief Executive Officer | Tax withheld | 4,956 | $176.9K |
| Feb 20, 2026 | Grashoff Christopher L. Chief Growth Officer | Tax withheld | 1,948 | $69.5K |
| Feb 20, 2026 | RADEMACHER JOHN CHARLES Chief Executive Officer | Tax withheld | 10,638 | $379.7K |
| Feb 20, 2026 | Smyser Collin GC & Corporate Secretary | Tax withheld | 2,012 | $71.8K |
| Feb 20, 2026 | Bavaro Michael Chief Human Resources Officer | Tax withheld | 1,187 | $42.4K |
| Feb 20, 2026 | Maggio Nicole Chief Accounting Officer | Tax withheld | 619 | $22.1K |
| Feb 20, 2026 | Whitworth Luke Chief Operating Officer | Tax withheld | 4,015 | $143.3K |
| Feb 18, 2026 | Maggio Nicole Chief Accounting Officer | Award | 4,226 | $0 |
| Feb 18, 2026 | RADEMACHER JOHN CHARLES Chief Executive Officer | Award | 78,876 | $0 |
| Feb 18, 2026 | Smyser Collin GC & Corporate Secretary | Award | 15,213 | $0 |
| Feb 18, 2026 | Adewunmi Femi Chief Medical Officer | Award | 9,579 | $0 |
| Feb 18, 2026 | Sethna Meenal Chief Financial Officer | Award | 27,045 | $0 |
| Feb 18, 2026 | Bavaro Michael Chief Human Resources Officer | Award | 9,579 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Option Care Health, Inc.
Free account. Everything above stays public.
Write why you follow Option Care Health, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading